IP & licensing
License proven, patent-protected cannabinoid delivery technology
TurgorTx offers CMOs, cannabinoid brands and medicinal cannabis companies structured access to its NLC formulation platform through licensing, co-development or technology transfer — without the time, cost or risk of building nanoencapsulation R&D from scratch.
Build vs license
Why license rather than build
Formulation R&D is a long, expensive road. Licensing shortens it.
Developing a validated lipid nanoparticle delivery system in-house requires specialised formulation expertise, analytical capability and — critically — freedom-to-operate against an increasingly crowded patent landscape in lipid nanoparticle technology. TurgorTx gives partners a faster, lower-risk route: access to an already patent-protected, formulation-validated NLC platform, adapted specifically for cannabinoid actives.
Value
What you gain
- 01
Access to IP-protected NLC formulation technology (WO2025005799A1 and related know-how)
- 02
Technical formulation support from a team with direct cannabinoid delivery experience
- 03
A shortened path from concept to a manufacturable, stable, bioavailability-optimised product
- 04
Reduced formulation and stability-failure risk ahead of scale-up
Pathways
Engagement models
- 01
Technology licensing
License TurgorTx's NLC formulation technology for use in your own manufacturing operation, under defined terms of use, active scope and territory. Suited to established CMOs with in-house manufacturing capability seeking to add a differentiated delivery technology to their offering.
- 02
Co-development
Work directly with TurgorTx's R&D team to develop a formulation tailored to a specific active, dose format or clinical application. Suited to brands and medicinal cannabis companies with a defined product concept requiring dedicated formulation development.
- 03
Technology transfer
For qualified manufacturing partners, TurgorTx supports structured transfer of formulation protocols and process know-how into a partner's own GMP-aligned production environment, subject to appropriate technical and quality alignment.
TurgorTx operates as a formulation R&D and technology licensing partner. Commercial-scale GMP manufacturing is arranged through qualified partner facilities or agreed manufacturing collaborations — contact us to discuss the right pathway for your production requirements.
Patent
IP position
TurgorTx's cannabinoid formulation technology is protected under patent WO2025005799A1, developed through our dedicated NLC formulation research program and refined across multiple lipophilic-active formulation projects. Licensing partners gain access to technology built on a documented, protected innovation record — not an open, easily copied formulation method.
For detailed IP scope, claims coverage and territory-specific licensing terms, our team can walk you through the relevant documentation under NDA.
WO2025005799A1